FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1

Abstract

Head and neck squamous cell carcinoma (HNSCC) still lacks effective targeted treatment. Therefore, exploring novel and robust molecular targets is critical for improving the clinical outcome of HNSCC. Here, we reported that the expression levels of family with sequence similarity 64, member A (FAM64A) were significantly higher in HNSCC tissues and cell lines. In addition, FAM64A overexpression was found to be strongly associated with an unfavorable prognosis of HNSCC. Both in vitro and in vivo evidence showed that FAM64A depletion suppressed the malignant activities of HNSCC cells, and vice versa. Moreover, we found that the FAM64A level was progressively increased from normal to dysplastic to cancerous tissues in a carcinogenic 4-nitroquinoline-1-oxide mouse model. Mechanistically, a physical interaction was found between FAM64A and forkhead box protein M1 (FOXM1) in HNSCC cells. FAM64A promoted HNSCC tumorigenesis not only by enhancing the transcriptional activity of FOXM1, but also, more importantly, by modulating FOXM1 expression via the autoregulation loop. Furthermore, a positive correlation between FAM64A and FOXM1 was found in multiple independent cohorts. Taken together, our findings reveal a previously unknown mechanism behind the activation of FOXM1 in HNSCC, and FAM64A might be a promising molecular therapeutic target for treating HNSCC.

References

[1] Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat. Rev. Cancer, 2018, 18: 269-282.

[2] Jiang Z, . Research on neck dissection for oral squamous-cell carcinoma: a bibliometric analysis. Int. J. Oral. Sci., 2021, 13: 13.

[3] Banerjee R, . Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab. Mol. Ther., 2022, 30: 468-484.

[4] Li Q, . Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma. Int. J. Oral. Sci., 2020, 12: 24.

[5] Johnson DE, . Head and neck squamous cell carcinoma. Nat. Rev. Dis. Prim., 2020, 6: 92.

[6] Chen W, . Downregulation of ceramide synthase 1 promotes oral cancer through endoplasmic reticulum stress. Int. J. Oral. Sci., 2021, 13: 10.

[7] Zhao X, Cui L. Development and validation of a m(6)A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma. Am. J. Cancer Res., 2019, 9: 2156-2169.

[8] Su SC, . A novel melatonin-regulated lncRNA suppresses TPA-induced oral cancer cell motility through replenishing PRUNE2 expression. J. Pineal Res., 2021, 71: e12760.

[9] Bray F, . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2018, 68: 394-424.

[10] Shin YY, . Melatonin and verteporfin synergistically suppress the growth and stemness of head and neck squamous cell carcinoma through the regulation of mitochondrial dynamics. J. Pineal Res., 2022, 72: e12779.

[11] Archangelo LF, Glasner J, Krause A, Bohlander SK. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10. Oncogene, 2006, 25: 4099-4109.

[12] Archangelo LF, . The CALM and CALM/AF10 interactor CATS is a marker for proliferation. Mol. Oncol., 2008, 2: 356-367.

[13] Xu ZS, . FAM64A positively regulates STAT3 activity to promote Th17 differentiation and colitis-associated carcinogenesis. Proc. Natl Acad. Sci. USA, 2019, 116: 10447-10452.

[14] Zhou Y, . FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer. Cell Death Dis., 2021, 12

[15] Zhang J, . Up-regulation of FAM64A promotes epithelial-to-mesenchymal transition and enhances stemness features in breast cancer cells. Biochem. Biophys. Res. Commun., 2019, 513: 472-478.

[16] Jiao Y, Fu Z, Li Y, Zhang W, Liu Y. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer. PLoS ONE, 2019, 14: e0211291.

[17] Zhao X, Sun S, Zeng X, Cui L. Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma. Am. J. Cancer Res., 2018, 8: 450-461.

[18] Qiu Y, . Development and validation of a robust immune prognostic signature for head and neck squamous cell carcinoma. Front. Oncol., 2020, 10: 1502.

[19] Jin Z, . UBE2C promotes the progression of head and neck squamous cell carcinoma. Biochem. Biophys. Res. Commun., 2020, 523: 389-397.

[20] Sacco AG, Cohen EE. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. J. Clin. Oncol., 2015, 33: 3305-3313.

[21] Aung KL, Siu LL. Genomically personalized therapy in head and neck cancer. Cancers Head Neck, 2016, 1: 2.

[22] Yao Z, . Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells. Breast Cancer, 2019, 26: 835-845.

[23] Jiang Y, . FAM64A promotes osteosarcoma cell growth and metastasis and is mediated by miR-493. J. Oncol., 2020, 2020: 2518297.

[24] Mizuno, K. et al. FAM64A: a novel oncogenic target of lung adenocarcinoma regulated by both strands of miR-99a (miR-99a-5p and miR-99a-3p). Cells 9, https://doi.org/10.3390/cells9092083 (2020).

[25] Bella L, Zona S, Nestal de Moraes G, Lam EW. FOXM1: A key oncofoetal transcription factor in health and disease. Semin Cancer Biol., 2014, 29: 32-39.

[26] Dai S, Qu L, Li J, Chen Y. Toward a mechanistic understanding of DNA binding by forkhead transcription factors and its perturbation by pathogenic mutations. Nucleic Acids Res., 2021, 49: 10235-10249.

[27] Besharat ZM, . Foxm1 controls a pro-stemness microRNA network in neural stem cells. Sci. Rep., 2018, 8

[28] Alvarez-Fernandez M, Medema RH. Novel functions of FoxM1: from molecular mechanisms to cancer therapy. Front. Oncol., 2013, 3: 30.

[29] Nandi D, Cheema PS, Jaiswal N, Nag A. FoxM1: Repurposing an oncogene as a biomarker. Semin Cancer Biol., 2018, 52: 74-84.

[30] Borhani S, Gartel AL. FOXM1: a potential therapeutic target in human solid cancers. Expert Opin. Ther. Targets, 2020, 24: 205-217.

[31] Ma X, . FOXM1 Promotes head and neck squamous cell carcinoma via activation of the linc-ROR/LMO4/AKT/PI3K axis. Front. Oncol., 2021, 11: 658712.

[32] Kalathil D, John S, Nair AS. FOXM1 and cancer: faulty cellular signaling derails homeostasis. Front. Oncol., 2020, 10: 626836.

[33] Teh MT, . FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma. PLoS ONE, 2012, 7: e34329.

[34] Gemenetzidis E, . FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS ONE, 2009, 4: e4849.

[35] Yang H, . FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop. Anticancer Drugs, 2018, 29: 216-226.

[36] Roh V, . The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma. J. Pathol., 2020, 250: 107-119.

[37] Eckers JC, . Forkhead box M1 regulates quiescence-associated radioresistance of human head and neck squamous carcinoma cells. Radiat. Res., 2014, 182: 420-429.

[38] Ma H, . Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas. Oncotarget, 2016, 7: 54555-54563.

[39] Chesnokov MS, . Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells. Cell Death Dis., 2021, 12

[40] Cui L, . Melatonin modulates metabolic remodeling in HNSCC by suppressing MTHFD1L-formate axis. J. Pineal Res., 2021, 71: e12767.

[41] Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res., 2004, 10: 7252-7259.

Funding

Guangdong Basic and Applied Basic Research Foundation (2020A1515110051) Science Research Cultivation Program of Stomatological Hospital, Southern Medical University (PY2020002)

National Natural Science Foundation of China (National Science Foundation of China)(81901006)

Scientific Research Talent Cultivation Project of Stomatological Hospital, Southern Medical University (RC202005)